Form 8-K - Current report:
SEC Accession No. 0001193125-16-801307
Filing Date
2016-12-22
Accepted
2016-12-22 09:41:04
Documents
7
Period of Report
2016-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d314338d8k.htm 8-K 30552
2 EX-2.1 d314338dex21.htm EX-2.1 558956
3 EX-10.1 d314338dex101.htm EX-10.1 54215
4 EX-10.2 d314338dex102.htm EX-10.2 146598
5 EX-99.1 d314338dex991.htm EX-99.1 17202
6 GRAPHIC g314338g1221214552032.jpg GRAPHIC 3065
7 GRAPHIC g314338g1221214552095.jpg GRAPHIC 3331
  Complete submission text file 0001193125-16-801307.txt   817877
Mailing Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109
Business Address 255 STATE STREET 6TH FLOOR BOSTON MA 02109 617-225-4348
Tokai Pharmaceuticals Inc (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36620 | Film No.: 162065215
SIC: 2834 Pharmaceutical Preparations